Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea · Delayed Price · Currency is KRW
8,830.00
+70.00 (0.80%)
Apr 1, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
|---|
| | 355.85B | 193.89B | 132.33B | 257.97B | 50.38B | | | | |
Diagnosis Bio Business Growth | | 83.53% | 46.53% | -48.70% | 412.01% | -8.53% | | | | |
| | 355.85B | 193.89B | 132.33B | 257.97B | 50.38B | | | | |
| | 83.53% | 46.53% | -48.70% | 412.01% | -8.53% | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 |
|---|
| | 17.80B | 89.33B | 23.00B | - | - | | | | |
| | -80.08% | 288.41% | - | - | - | | | | |
| | 20.56B | 28.41B | 38.61B | 109.54B | 21.20B | | | | |
| | -27.64% | -26.42% | -64.75% | 416.71% | -17.76% | | | | |
| | 11.12B | 16.15B | 20.18B | 48.79B | 22.73B | | | | |
| | -31.13% | -19.96% | -58.65% | 114.66% | -10.00% | | | | |
| | 292.71B | 39.22B | 16.82B | 40.43B | - | | | | |
| | 646.37% | 133.19% | -58.40% | - | - | | | | |
| | 8.25B | 15.64B | 28.38B | 36.02B | - | | | | |
| | -47.27% | -44.90% | -21.20% | - | - | | | | |
| | 5.42B | 5.15B | 5.34B | 23.20B | 5.12B | | | | |
| | 5.28% | -3.58% | -76.99% | 352.67% | 71.82% | | | | |
| | - | - | - | - | 1.33B | | | | |
| | - | - | - | - | 24.55% | | | | |
| | 355.85B | 193.89B | 132.33B | 257.97B | 50.38B | | | | |
| | 83.53% | 46.53% | -48.70% | 412.01% | -8.53% | | | | |
Source: S&P Global Market Intelligence.